First Choice Healthcare Solutions (FCHS) 10-Q 15 May 17 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 12, 2017
Document And Entity Information
Entity Registrant Name	First Choice Healthcare Solutions, Inc.
Entity Central Index Key	1,416,876
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		26,803,994
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,017

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents (amounts related to VIE of $908,141 and $708,858)	$ 3,901,489	$ 4,593,638
Accounts receivable, net (amounts related to VIE of $6,112,966 and $6,010,961)	10,390,140	9,536,830
Employee loans (amounts related to VIE of $491,550 and $491,850)	953,132	820,341
Prepaid and other current assets (amounts related to VIE of $392,961 and $329,427)	651,770	422,512
Total current assets	15,896,531	15,373,321
Property, plant and equipment, net of accumulated depreciation of $1,264,271 and $1,165,219 (amounts related to VIE of $678,018 and $693,629)	2,619,493	2,544,816
Other assets (amounts related to VIE of $921,470)	4,137,521	4,227,957
Total assets	22,653,545	22,146,094
Current liabilities:
Accounts payable and accrued expenses (amounts related to VIE of $1,638,148 and $1,366,143)	2,437,080	2,083,231
Accounts payable, related party (amount related to VIE of $251,588)	251,588	251,588
AMT Tax Payable	181,029	181,029
Line of credit, short term (amount related to VIE of $439,524)	1,539,524	1,539,524
Notes payable, current portion	402,372	519,452
Unearned revenue	43,854	26,936
Deferred rent, short term portion (amount related to VIE of $237,923)	237,923	237,923
Total current liabilities	5,093,370	4,839,683
Long term debt:
Deposits held	41,930	41,930
Notes payable, long term portion	23,599	14,531
Deferred rent, long term portion (amount related to VIE of $2,240,552 and $2,214,909)	2,345,465	2,293,594
Total long term debt	2,410,994	2,350,055
Total liabilities	7,504,364	7,189,738
Equity:
Preferred stock, $0.01 par value; 1,000,000 shares authorized, Nil issued and outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized, 26,803,994 and 24,631,327 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively	26,804	24,631
Additional paid in capital	24,081,761	24,020,610
Accumulated deficit	(9,898,015)	(10,100,534)
Total stockholders' equity attributable to First Choice Healthcare Solutions, Inc.	14,210,550	13,944,707
Non-controlling interest (note 10)	938,631	1,011,649
Total equity	15,149,181	14,956,356
Total liabilities and equity	$ 22,653,545	$ 22,146,094

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Prepaid and other current assets	$ 651,770	$ 422,512
Property, plant and equipment, net of accumulated depreciation	1,264,271	1,165,219
Other assets	4,137,521	4,227,957
Accounts payable and accrued expenses	2,437,080	2,083,231
Accounts payable, related party	251,588	251,588
Line of credit, short term	1,539,524	1,539,524
Deferred rent, short term portion	237,923	237,923
Deferred rent, long term portion	$ 2,345,465	$ 2,293,594
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	26,803,994	24,631,327
Common stock, shares outstanding	26,803,994	24,631,327
VIE [Member]
Cash Related to VIE	$ 908,141	$ 708,858
Accounts receivable	6,112,966	6,010,961
Employee loans	491,550	491,850
Prepaid and other current assets	392,961	329,427
Property, plant and equipment, net of accumulated depreciation	678,018	693,629
Other assets	921,470	921,470
Accounts payable and accrued expenses	1,638,148	1,366,143
Accounts payable, related party	251,588	251,588
Line of credit, short term	439,524	439,524
Deferred rent, short term portion	237,923	237,923
Deferred rent, long term portion	$ 2,240,552	$ 2,214,909

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenues:
Patient service revenue	$ 7,406,986	$ 6,877,665
Allowance for bad debts	(264,996)	(262,524)
Net patient service revenue less provision for bad debts	7,141,990	6,615,141
Rental revenue	578,363	626,612
Total revenue	7,720,353	7,241,753
Operating expenses:
Salaries and benefits	3,354,376	2,780,569
Other operating expenses	2,529,183	2,045,575
General and administrative	1,535,833	1,547,576
Depreciation and amortization	189,488	298,950
Total operating expenses	7,608,880	6,672,670
Net income from operations	111,473	569,083
Other income (expense):
Gain on sale of property and improvements		9,188,968
Miscellaneous income (expense)	50,102	58,857
Amortization financing costs		(15,325)
Interest expense	(32,074)	(181,135)
Total other income	18,028	9,051,365
Net income before provision for income taxes	129,501	9,620,448
Income taxes (benefit)
Net income	129,501	9,620,448
Non-controlling interest (note 10)	73,018	(53,507)
NET INCOME ATTRIBUTABLE TO FIRST CHOICE HEALTHCARE SOLUTIONS, INC.	$ 202,519	$ 9,566,941
Net income per common share, basic	$ 0.01	$ 0.42
Net income per common share, diluted	$ 0.01	$ 0.37
Weighted average number of common shares outstanding, basic	26,252,505	22,886,307
Weighted average number of common shares outstanding, diluted	27,052,505	25,552,974

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - 3 months ended Mar. 31, 2017 - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interest	Total
Beginning Balance, Amount at Dec. 31, 2016	$ 24,631	$ 24,020,610	$ (10,100,534)	$ 1,011,649	$ 14,956,356
Beginning Balance, Shares at Dec. 31, 2016	24,631,327
Common stock issued in settlement of convertible debt, previously accrued, Amount	$ 1,867	(1,867)
Common stock issued in settlement of convertible debt, previously accrued, Shares	1,866,667
Stock based compensation previously accrued, Amount	$ 306	63,018			63,324
Stock based compensation previously accrued, Shares	306,000
Net income			202,519	(73,018)	202,519
Ending Balance, Amount at Mar. 31, 2017	$ 26,804	$ 24,081,761	$ (9,898,015)	$ 938,631	$ 15,149,181
Ending Balance, Shares at Mar. 31, 2017	26,803,994

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ 129,501	$ 9,620,448
Adjustments to reconcile net income to cash (used in) provided by operating activities:
Depreciation and amortization	189,488	298,950
Amortization of financing costs		15,325
Bad debt expense	264,996	262,524
Gain on sale of property		(9,188,968)
Common stock issued in connection with loan extension		92,000
Stock based compensation	63,324	81,300
Changes in operating assets and liabilities:
Accounts receivable	(1,118,306)	(1,087,059)
Prepaid expenses and other current assets	(229,258)	91,623
Restricted funds		359,414
Employee loans	(132,791)	(245,933)
Accounts payable and accrued expenses	353,849	122,628
Settlement payable		(150,000)
Deposits		(14,432)
Deferred rent	51,871	59,404
Unearned income	16,918
Net cash (used in) provided by operating activities	(410,408)	317,224
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of property		15,068,497
Purchase of equipment	(173,729)	(126,073)
Net cash (used in) provided by investing activities	(173,729)	14,942,424
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from advances		90,714
Proceeds from notes payable	22,113
Proceeds from line of credit		372,636
Payments on notes payable	(130,125)	(7,265,997)
Net cash used in financing activities	(108,012)	(6,802,647)
Net (decrease) increase in cash and cash equivalents	(692,149)	8,457,001
Cash and cash equivalents, beginning of period	4,593,638	1,594,998
Cash and cash equivalents, end of period	3,901,489	10,051,999
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the period for interest	32,328	181,135
Cash paid during the period for taxes

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Mar. 31, 2017
Basis Of Presentation
BASIS OF PRESENTATION	NOTE 1 — BASIS OF PRESENTATION A summary of the significant accounting policies applied in the presentation of the accompanying unaudited condensed consolidated financial statements follows: General The (a) condensed consolidated balance sheet as of December 31, 2016, which has been derived from the audited financial statements of First Choice Healthcare Solutions, Inc. (“FCHS” and including, where appropriate, its consolidated subsidiaries and entities in which we have a controlling financial interest, the “Company”), and (b) the unaudited condensed consolidated interim financial statements as of March 31, 2017 and 2016 of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. To determine if we hold a controlling financial interest in an entity, we first evaluate if we are required to apply the variable interest entity (“VIE”) model to the entity, otherwise the entity is evaluated under the voting interest model. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2017 are not necessarily indicative of results that may be expected for the year ending December 31, 2017. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2016 included in the Company’s Annual Report on Form 10-K/A, filed with the Securities and Exchange Commission (the “SEC”) on April 3, 2017. Basis of Presentation Effective April 4, 2012, Medical Billing Assistance, Inc., a Colorado corporation (“Medical Billing”), merged with and into the Company. The effect of the merger was that Medical Billing reincorporated from Colorado to Delaware (the “Reincorporation”). The Company is deemed to be the successor issuer of Medical Billing under Rule 12g-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Other than the foregoing, the Reincorporation did not result in any change in the business, management, fiscal year, accounting, and location of the principal executive offices, assets or liabilities of the Company. On April 2, 2012, the Company completed its acquisition of First Choice Medical Group of Brevard, LLC (“FCMG - Brevard”), pursuant to the Membership Interest Purchase Closing Agreement (the “Purchase Agreement”). The Company has been managing the practice of First Choice – Brevard since November 1, 2011, pursuant to a Management Services Agreement. Brevard Orthopedic Spine & Pain Clinic, Inc. Effective May 1, 2015, the Company, through its wholly owned subsidiary, TBC Holdings of Melbourne, Inc., entered into an Operating and Control Agreement (the Agreement”) with Brevard Orthopaedic Spine & Pain Clinic, Inc. (“The B.A.C.K. Center”), whereby we have sole and exclusive management and control of The B.A.C.K. Center, including, but not limited to, administrative, financial, facility and business operations including the requirement to absorb losses or right to receive economic benefits. We issued 3,000,000 options to purchase our Company’s Common Stock at $1.35 per share to The B.A.C.K. Center employees providing specific qualifications are met. The initial term of the Agreement relating to the options expired on December 31, 2016, with the Company having the right to extend the term until December 31, 2023. We exercised our option to extend the term until December 31, 2017. The Agreement allows the Company to hold the current or potential rights that give it the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, combined with a variable interest that gives the Company the right to receive potentially significant benefits or the obligation to absorb potentially significant losses. The Company has a controlling financial interest in the VIE. Rights held by others to remove the party with power over the VIE are not considered unless one party can exercise those rights unilaterally. When changes occur to the structure of the entity, the Company will reconsider whether it is subject to the VIE model. The Company continuously evaluates whether it has a controlling financial interest in the VIE. Crane Creek Surgery Center Effective October 1, 2015, the Company, through its wholly owned subsidiary, CCSC Holdings, Inc., acquired a 40% interest in Crane Creek Surgery Center (“Crane Creek”).In connection with the investment, the Company is entitled to 51% voting rights for all decisions that most significantly affect the economic performance of Crane Creek. The 40% equity interest acquired entitles the Company to 40% of the profit or loss of Crane Creek. Non-controlling interests relate to the third-party ownership in a consolidated entity in which the Company has a controlling interest. For financial reporting purposes, the entity’s assets, liabilities, and operations are consolidated with those of the Company, and the non-controlling interest in the entity is included in the Company’s consolidated financial statements within the equity section of the consolidated Balance Sheets. The unaudited condensed consolidated financial statements include the accounts of the Company and its direct and indirect wholly owned subsidiaries: Marina Towers, LLC, FCID Medical Inc., TBC Holdings of Melbourne, Inc., First Choice – Brevard, Surgical Partners of Melbourne, Inc. and CCSC Holdings, Inc., along with two VIEs, The B.A.C.K. Center and Crane Creek. All significant intercompany balances and transactions, including those involving the VIEs, have been eliminated in consolidation.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2017
Significant Accounting Policies
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 — SIGNIFICANT ACCOUNTING POLICIES Use of estimates The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates include the recoverability and useful lives of long-lived assets, provision against bad debt, the fair value of the Company’s stock, and stock-based compensation. Actual results may differ from these estimates. Revenue recognition The Company recognizes revenue when: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed or determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. ASC 605-10 incorporates Accounting Standards Codification subtopic 605-25, “ Multiple-Element Arrangements The Company recognizes in accordance with Accounting Standards Codification subtopic 954-310, “Health Care Entities” (“ASC 954-310”), significant patient service revenue at the time the services are rendered, even though it does not assess the patient’s ability to pay. Therefore, The Company’s interim and annual periods reports disclose both, its policy for assessing and disclosing the timing and amount of uncollectable patient service revenue recognized as doubtful. Qualitative and quantitative information about significant changes in the allowance for doubtful accounts related to patient accounts receivable are disclosed in the Company’s reports. These estimates are based upon the history and identified trends for each of our payers. Patient service revenue The Company recognizes patient service revenue associated with services provided to patients who have third-party payer coverage on the basis of contractual rates for the services provided. For uninsured or self-pay patients that do not qualify for charity care, the Company recognizes revenue on the basis of its standard rates for services provided (or on the basis of discounted rates, if negotiated or provided by policy). On the basis of historical experience, a portion of the Company’s patient service revenue may be potentially uncollectible due to patients who are unable or unwilling to pay for the services provided or the portion of their bill for which they are responsible. Thus, the Company records a provision for bad debts related to potentially uncollectible patient service revenue in the period the services are provided. Concentrations of credit risk The Company’s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. Occasionally, the Company’s cash and cash equivalents in interest-bearing accounts may exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management. Revenues and accounts receivable are concentrated between two major payers, Medicare at approximately 30% and a third party commercial insurer at approximately 20%. Accounts receivables As of March 31, 2017 and December 31, 2016, the Company’s allowance for bad debts was $3,750,802 and $3,680,837, respectively. Net income per share Basic net income per common share is based upon the weighted-average number of common shares outstanding. Diluted net income per common share is based on the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding and computed as follows: Three months ended March 31, 2017 2016 Numerator: Net income $ 202,519 $ 9,566,941 Denominator: Weighted-average common shares, basic 26,252,505 22,886,307 Weighted-average common shares, diluted 27,052,505 25,552,974 Basic: $ 0.01 $ 0.42 Diluted: $ 0.01 $ 0.37 The diluted earnings per common share included the effect of 800,000 and 2,666,667 common shares issuable upon the conversion of debt for the three months ended March 31, 2017 and 2016, respectively. Potentially dilutive common shares from employee equity plans and issued warrants are determined by applying the treasury stock method to the assumed exercise of warrants and share options are were excluded from the computation of the diluted net income per share because their inclusion would be anti-dilutive. In addition, there were no vested restrict stock for periods presented. Potentially dilutive securities excluded from the basic and diluted net income per share are as follows: March 31, 2017 2016 Warrants to purchase common stock 1,875,000 4,324,630 Options to purchase common stock 3,000,000 3,000,000 Restricted stock awards 660,000 — 5,535,000 7,324,630 Reclassification Certain reclassifications have been made to prior periods’ data to conform to the current year’s presentation. These reclassifications had no effect on reported income or losses. Recent accounting pronouncements There are updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s financial position, results of operations or cash flows. In January 2017, the FASB issued Accounting Standards Update (“ASU”) 2017-04, Intangibles – Goodwill and Other (Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. Subsequent events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed.

LIQUIDITY

LIQUIDITY	3 Months Ended
	Mar. 31, 2017
Liquidity Disclosures [Abstract]
LIQUIDITY	NOTE 3 – LIQUIDITY The Company incurred various non-recurring expenses in 2016 in connection with the planned development of its Healthcare Services Business. Management believes continued growth of earnings before interest, taxes, depreciation and amortization in 2017 will support improved liquidity. The Company believes that the current cash balance and line of credit (see notes), along with continued execution of its business development plan, will allow the Company to further improve its working capital; and currently anticipates that it will have sufficient capital resources to meet projected cash flow requirements through the date at least one year from the filing of this report. However, in order to execute the Company’s business development plan, which there can be no assurance we will achieve, the Company may need to raise additional funds through public or private equity offerings, debt financings, corporate collaborations or other means and potentially reduce operating expenditures. If the Company is unable to secure additional capital, it may be required to curtail its business development initiatives and take additional measures to reduce costs in order to conserve its cash.

OTHER ASSETS

OTHER ASSETS	3 Months Ended
	Mar. 31, 2017
Other Assets [Abstract]
OTHER ASSETS	NOTE 4 — OTHER ASSETS Other assets are comprised of the following: March 31, 2017 December 31, 2016 Goodwill (amount relating to VIE of $899,465) $ 899,465 $ 899,465 Deferred costs, net of amortization of $618,401 and $537,740 2,608,026 2,688,687 Patient list, net of accumulated amortization of $100,000 and $95,000 200,000 205,000 Patents, net of accumulated amortization of $62,075 and $57,300 224,425 229,200 Investments (amounts related to VIE of $22,005) 22,005 22,005 Deferred tax asset 181,029 181,029 Deposits 2,571 2,571 Total other assets $ 4,137,521 $ 4,227,957

LINES OF CREDIT

LINES OF CREDIT	3 Months Ended
	Mar. 31, 2017
Line of Credit Facility [Abstract]
LINES OF CREDIT	NOTE 5 — LINES OF CREDIT Line of credit, CT Capital FCMG - Brevardentered into a Loan and Security Agreement (the “Loan Agreement”) with CT Capital, Ltd., d/b/a CT Capital, LP, a Florida limited liability partnership (the “Lender”). Under the Loan Agreement, the Lender committed to make an accounts receivable line of credit in the maximum aggregate amount of $2,500,000 to FCMG - Brevard with an interest rate of 6% per annum (the “Loan”). The maturity date of the Loan is June 30, 2017. Interest is due and payable monthly. The Lender may convert up to $2,000,000 of the outstanding principal amount or interest on the Loan into common stock of the Company at a conversion price of $0.75 per share. On March 30, 2017, the Company’s Loan and Security Agreement with CT Capital, Ltd. (“Lender”) was amended to extend the Maturity Date to June 30, 2018 (the “Loan”) and further provide that neither the Company nor Lender shall effectuate any conversion of the Loan to the extent that after giving effect to any such conversion, the Lender would beneficially own in excess of 9.99% of the number of shares of our Company’s shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Loan by the Lender. As of March 31, 2017 and December 31, 2016, the outstanding balance was $1,100,000 and the remaining principal amount the Lender can convert into common stock is $600,000. Line of credit, Florida Business Bank The B.A.C.K. Center is a party to a Promissory Note (the “Loan Agreement”) with Florida Business Bank, a Florida banking corporation (the “Lender”). Under the Loan Agreement, the Lender committed to make an accounts receivable line of credit in the maximum aggregate amount of $1,383,000 (as amended), with an interest rate of Prime floating plus 1.0%, as published in The Wall Street Journal Interest shall be due and payable monthly and principal is due on demand. The outstanding principal balance plus all accrued but unpaid interest shall be due on demand (the “Maturity Date”). Upon default, the interest may be adjusted to the highest rate permissible by law. The Loan is secured by all assets of The B.A.C.K. Center now owned or hereafter acquired. The assets constitute the collateral for the repayment of the Loan. The Loan Agreement also includes covenants, representations, warranties, indemnities and events of default that are customary for facilities of this type. The advance rate is defined as: 60% of eligible accounts receivables. Eligible receivables include all Medicare and Medicaid receivables less than 90 days old multiplied by a factor of 0.25, plus all other receivables less than 90 days old multiplied by a factor of 0.50. As of March 31, 2017, The B.A.C.K. Center had not violated the loan covenants. The obligations of The B.A.C.K Center under the Loan Agreement are guaranteed by the shareholders of The B.A.C.K. Center. The Loan Agreement is also guaranteed in the amount of $950,000 by related parties of The B.A.C.K. Center. As of March 31, 2017 and December 31, 2016, the outstanding balance on the Loan was $439,524.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 — COMMITMENTS AND CONTINGENCIES Litigations, Claims and Assessments From time to time, we may become involved in lawsuits and legal proceedings which arise in the ordinary course of business including potential disputes with patients. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. Our contracts with hospitals generally requires us to indemnify them and their affiliates for losses resulting from the negligence of our physicians. Currently, we have no pending litigation that is deemed to be material.

CAPITAL STOCK

CAPITAL STOCK	3 Months Ended
	Mar. 31, 2017
Stockholders' Equity Note [Abstract]
CAPITAL STOCK	NOTE 7 — CAPITAL STOCK During the three months ended March 31, 2017, the Company issued an aggregate of 306,000 shares of its common stock to officers, employees and service providers at an aggregate fair value of $301,840, which were earned and expensed in 2016. During the three months ended March 31, 2017, the Company issued 1,866,667 shares of its common stock in exchange for $1,400,000 in convertible debt. The value of shares was recorded as a share issuance liability as of December 31, 2016 and issued in the first quarter of 2017.

STOCK OPTIONS, WARRANTS AND RES

STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK UNITS	3 Months Ended
	Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK UNITS	NOTE 8 — STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK UNITS Restricted Stock Units (“RSU”) The following table summarizes the restricted stock activity for the three months ended March 31, 2017: Restricted shares units issued as of December 31, 2016 660,000 Granted — Forfeited — Total Restricted Shares Issued at March 31, 2017 660,000 Vested at March 31, 2017 — Unvested restricted shares as of March 31, 2017 660,000 At March 31, 2017, the Company determined that there is a 100% probability the performance based restricted stock units will be earned. The fair value of all restricted stock units vesting during the three months ended March 31, 2017 and 2016 of $63,324 and $-0-, respectively, was charged to current period operations. As of March 31, 2017, stock-based compensation related to restricted stock awards of $488,830 remains unamortized and is expected to be amortized over the weighted average remaining period of 2.13 years.

VARIABLE INTEREST ENTITY

VARIABLE INTEREST ENTITY	3 Months Ended
	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
VARIABLE INTEREST ENTITY	NOTE 9 — VARIABLE INTEREST ENTITY Brevard Orthopaedic Spine & Pain Clinic, Inc. Effective May 1, 2015, the Company, through its wholly owned subsidiary, TBC Holdings of Melbourne, Inc., entered into an Operating and Control Agreement (the “Agreement”) with Brevard Orthopaedic Spine & Pain Clinic, Inc. (“The B.A.C.K. Center”), whereby we have sole and exclusive management and control of The B.A.C.K. Center, including, but not limited to, administrative, financial, facility and business operations including the requirement to absorb losses or right to receive economic benefits. We issued 3,000,000 options to purchase our Company’s Common Stock at $1.35 per share with vesting contingent on The B.A.C.K. Center employees signing employment contracts with First Choice – Brevard. The initial term of the Agreement relating to the options expired on December 31, 2016, with the Company having the right to extend the term until December 31, 2023. We exercised our option to extend the term until December 31, 2017. The Company has determined that The B.A.C.K. Center is a Variable Interest Entity (“VIE”) . In determining whether the Company has the right to receive benefits or the obligation to absorb losses that could potentially be significant to the VIE, the Company evaluates all of its economic interests in the entity, regardless of form (debt, equity, management and servicing fees, and other contractual arrangements). This evaluation considers all relevant factors of the entity’s structure, including: the entity’s capital structure, contractual rights to earnings (losses), subordination of our interests relative to those of other investors, contingent payments, as well as other contractual arrangements that have potential to be economically significant. The evaluation of each of these factors in reaching a conclusion about the potential significance of the Company’s economic interests is a matter that requires the exercise of professional judgment. The assets of The B.A.C.K. Center can only be used to settle obligations of the VIE, additionally, creditors of The B.A.C.K. Center do not have recourse against the general credit of the primary beneficiary. The tables below summarize the assets and liabilities associated with The B.A.C.K. Center as of March 31, 2017 and December 31, 2016: March 31, 2017 December 31, 2016 Current assets: Cash $ 813,427 $ 355,491 Accounts receivable 4,826,389 4,830,054 Other current assets 772,001 691,847 Total current assets 6,411,817 5,877,392 Property and equipment, net 71,226 70,444 Other assets 22,005 22,005 Total assets $ 6,505,048 $ 5,969,841 Current liabilities: Accounts payable and accrued liabilities $ 1,242,054 $ 904,684 Due to First Choice Healthcare Solutions, Inc. 3,040,529 2,867,539 Other current liabilities 677,447 677,446 Total current liabilities 4,960,030 4,449,669 Long term debt 1,683,704 1,658,858 Total liabilities 6,643,734 6,108,527 Non-controlling interest (138,686 ) (138,686 ) Total liabilities and deficit $ 6,505,048 $ 5,969,841 Total revenues from The B.A.C.K. Center were $3,430,655 for the three months ended March 31, 2017. Related expenses consisted primarily of salaries and benefits of $1,718,717, operating expenses of $856,482, general and administrative expenses of $720,232, depreciation of $6,162, interest and financing costs of $3,904; and other income of $45,684 for the three months ended March 31, 2017. (See Note 11 – Segment Reporting) Total revenues from The B.A.C.K. Center were $3,392,997 for the three months ended March 31, 2016. Related expenses consisted primarily of salaries and benefits of $1,457,911, operating expenses of $858,301, general and administrative expenses of $723,492, depreciation of $5,515 and interest and financing costs of $3,447 and other income of $56,725. (See Note 11 – Segment Reporting) Crane Creek Surgery Center Effective October 1, 2015, the Company, through its then newly formed wholly owned subsidiary, CCSC Holdings, Inc., acquired a 40% interest in Crane Creek Surgery Center (“Crane Creek”). In connection with the investment, the Company is entitled to 51% voting rights for all decisions that most significantly affect the economic performance of Crane Creek. The 40% equity interest acquired entitles the Company to 40% of the profit or loss of Crane Creek. The Company has determined that Crane Creek is a Variable Interest Entity (“VIE”) . This evaluation requires consideration of all facts and circumstances relevant to decision-making that affects the entity’s future performance and the exercise of professional judgment in deciding which decision-making rights are most important. In determining whether the Company has the right to receive benefits or the obligation to absorb losses that could potentially be significant to the VIE, the Company evaluates all of its economic interests in the entity, regardless of form (debt, equity, management and servicing fees, and other contractual arrangements). This evaluation considers all relevant factors of the entity’s structure, including: the entity’s capital structure, contractual rights to earnings (losses), subordination of our interests relative to those of other investors, contingent payments, as well as other contractual arrangements that have potential to be economically significant. The evaluation of each of these factors in reaching a conclusion about the potential significance of the Company’s economic interests is a matter that requires the exercise of professional judgment. The assets of Crane Creek can only be used to settle obligations of the VIE, additionally, creditors of the Crane Creek do not have recourse against the general credit of the primary beneficiary. The tables below summarize the assets and liabilities associated with the Crane Creek as of March 31, 2017 and December 31, 2016: March 31, 2017 December 31, 2016 Current assets: Cash $ 94,714 $ 353,367 Accounts receivable 1,286,577 1,180,907 Other current assets 112,510 129,430 Total current assets 1,493,801 1,663,704 Property and equipment, net 606,792 623,185 Goodwill 899,465 899,465 Total assets $ 3,000,058 $ 3,186,354 March 31, 2017 December 31, 2016 Current liabilities: Accounts payable and accrued liabilities $ 396,094 $ 461,489 Other current liabilities 251,588 251,588 Total current liabilities 647,682 713,077 Deferred rent 556,848 556,051 Total liabilities 1,204,530 1,269,128 Equity-First Choice Healthcare Solutions, Inc. 718,211 766,891 Non-controlling interest 1,077,317 1,150,335 Total liabilities and deficit $ 3,000,058 $ 3,186,354 Total revenues from Crane Creek were $1,190,425 for the three months ended March 31, 2017. Related expenses consisted primarily of salaries and benefits of $298,299, surgical supplies and operating expenses of $852,122, general and administrative expenses of $136,354, depreciation of $28,149, interest expense of $866 and miscellaneous income of $3,668 for the three months ended March 31, 2017. (See Note 11 – Segment Reporting) Total revenues from the Crane Creek were $1,271,308 for the three months ended March 31, 2016. Related expenses consisted primarily of salaries and benefits of $293,337, surgical supplies and operating of $709,646, general and administrative expenses of $109,275, depreciation of $71,256, interest expense of $8,726 and miscellaneous income of $1,382. (See Note 11 – Segment Reporting)

NON-CONTROLLING INTEREST

NON-CONTROLLING INTEREST	3 Months Ended
	Mar. 31, 2017
Noncontrolling Interest [Abstract]
NON-CONTROLLING INTEREST	NOTE 10 — NON-CONTROLLING INTEREST Effective May 1, 2015, the Company, through its wholly owned subsidiary, TBC Holdings of Melbourne, Inc., entered into an Operating and Control Agreement (the Agreement”) with Brevard Orthopaedic Spine & Pain Clinic, Inc. (“The B.A.C.K. Center”), whereby we have sole and exclusive management and control of The B.A.C.K. Center, including, but not limited to, administrative, financial, facility and business operations including the requirement to absorb losses or right to receive economic benefits. We issued 3,000,000 options to purchase our Company’s Common Stock at $1.35 per share with vesting contingent on The B.A.C.K. Center employees signing employment contracts with First Choice – Brevard. The initial term of the Agreement relating to the options expired on December 31, 2016, with the Company having the right to extend the term until December 31, 2023. We exercised our option to extend the term until December 31, 2017. A reconciliation of the non-controlling income attributable to the Company: Net income attributable to non-controlling interest for the three months ended March 31, 2017: Net income $ 170,842 Average Non-controlling interest percentage of profit/losses -0- % Net income attributable to the non-controlling interest $ -0- Net loss attributable to non-controlling interest for the three months ended March 31, 2016: Net income $ 328,741 Average Non-controlling interest percentage of profit/losses -0- % Net income attributable to the non-controlling interest $ -0- The following table summarizes the changes in non-controlling interest from December 31, 2016 through March 31, 2017: Balance, December 31, 2016 $ (138,686 ) Transfer (to) from the non-controlling interest as a result of change in ownership — Net income attributable to the non-controlling interest — Balance, March 31, 2017 $ (138,686 ) Effective October 1, 2015, the Company, through its wholly owned subsidiary, CCSC Holdings, Inc., acquired a 40% interest in Crane Creek Surgery Center (“Crane Creek”). In connection with the investment, the Company is entitled to 51% voting rights for all decisions that most significantly affect the economic performance of Crane Creek. The 40% equity interest acquired entitles the Company to 40% of the profit or loss of Crane Creek. A reconciliation of the non-controlling income attributable to the Company: Net loss attributable to non-controlling interest for the three months ended March 31, 2017: Net loss $ (121,698 ) Average Non-controlling interest percentage of profit/losses 60 % Net income/loss attributable to the non-controlling interest $ (73,018 ) Net income attributable to non-controlling interest for the three months ended March 31, 2016: Net income $ 89,177 Average non-controlling interest percentage of profit/losses 60 % Net income/loss attributable to the non-controlling interest $ 53,507 The following table summarizes the changes in non-controlling interest from December 31, 2016 through March 31, 2017: Balance, December 31, 2016 1,150,335 Transfer (to) from the non-controlling interest as a result of change in ownership — Net income attributable to the non-controlling interest (73,018 ) Balance, March 31, 2017 $ 1,077,317

SEGMENT REPORTING

SEGMENT REPORTING	3 Months Ended
	Mar. 31, 2017
Segment Reporting [Abstract]
SEGMENT REPORTING	NOTE 11 — SEGMENT REPORTING The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable segments. The Company has three reportable segments: FCID Medical, Inc., The B.A.C.K. Center and CCSC Holdings, Inc. (“CCSC”). All reportable segments derive revenue for medical services provided to patients; and The B.A.C.K Center additionally derives revenue for subleasing space within its building and medical services provided to patients. With the aforementioned sale and leaseback of Marina Towers on March 31, 2016, the Company will no longer report segmented rental revenue received from third-party Marina Tower tenants under the segment heading “Marina Towers.” Rather, the Company has consolidated rental revenue received from third-party tenants of Marina Towers under the “Corporate” segment for both the 2017 and 2016 comparable reporting periods; and will continue to do so hereafter. Information concerning the operations of the Company’s reportable segments is as follows: Summary Statement of Income for the three months ended March 31, 2017: The FCID B.A.C.K. Intercompany Medical Center CCSC Corporate Eliminations Total Revenue: Net Patient Service Revenue $ 2,860,986 $ 3,090,579 $ 1,190,425 $ — $ — $ 7,141,990 Rental revenue — 340,076 431,850 (193,563 ) 578,363 Total Revenue 2,860,986 3,430,655 1,190,425 431,850 (193,563 ) 7,720,353 Operating expenses: Salaries & benefits 1,095,236 1,718,717 298,299 242,124 3,354,376 Other operating expenses 591,151 856,482 852,122 408,861 (179,433 ) 2,529,183 General and administrative 525,309 638,798 136,354 249,502 (14,130 ) 1,535,833 Depreciation and amortization 69,741 6,162 28,149 85,436 — 189,488 Total operating expenses 2,281,437 3,220,159 1,314,924 985,923 (193,563 ) 7,608,880 Net income (loss) from operations: 579,549 210,496 (124,499 ) (554,073 ) — 111,473 Interest income (expense) (27,558 ) (3,904 ) (866 ) 254 — (32,074 ) Other income — 45,684 3,668 750 — 50,102 Net Income (Loss) before income taxes: 551,991 252,276 (121,697 ) (553,069 ) — 129,501 Income taxes — — — — Net income (Loss) 551,991 252,276 (121,697 ) (553,069 ) — 129,501 Non-controlling interest — — 73,018 — — 73,018 Net income (loss) attributable to First Choice Healthcare Solutions $ 551,991 $ 252,276 $ (48,679 ) $ (553,069 ) $ — $ 202,519 17 FIRST CHOICE HEALTHCARE SOLUTIONS, INC. NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS March 31, 2017 Summary Statement of Income for the three months ended March 31, 2016: The FCID B.A.C.K. Intercompany Medical Center CCSC Corporate Eliminations Total Revenue: Net Patient Service Revenue $ 2,308,935 $ 3,034,898 $ 1,271,308 $ — $ — $ 6,615,141 Rental revenue — 358,099 428,246 (159,733 ) 626,612 Total Revenue 2,308,935 3,392,997 1,271,308 428,246 (159,733 ) 7,241,753 Operating expenses: Salaries & benefits 829,220 1,457,911 293,337 200,101 — 2,780,569 Other operating expenses 531,407 858,301 709,646 105,954 (159,733 ) 2,045,575 General and administrative 361,803 723,492 109,275 353,006 — 1,547,576 Depreciation and amortization 66,792 5,515 71,256 155,387 — 298,950 Total operating expenses 1,789,222 3,045,219 1,183,514 814,448 (159,733 ) 6,672,670 Net income (loss) from operations: 519,713 347,778 87,794 (386,202 ) — 569,083 Interest income (expense) (56,818 ) (2,459 ) (8,726 ) (113,132 ) — (181,135 ) Amortization of financing costs — (988 ) — (14,337 ) — (15,325 ) Gain on sale of property — — — 9,188,968 — 9,188,968 Other income (expense) — 56,725 1,382 750 — 58,857 Net Income (loss) before income taxes: 462,895 401,056 80,450 8,676,047 — 9,620,448 Income taxes — — — — Net income 462,895 401,056 80,450 8,676,047 — 9,620,448 Non-controlling interest — — (53,507 ) — — (53,507 ) Net income attributable to First Choice Healthcare Solutions $ 462,895 $ 401,056 $ 26,943 $ 8,676,047 $ — $ 9,566,941 Selected financial data: FCID Brevard The Crane Medical Orthopaedic Center Corporate Total Assets: At March 31, 2017: $ 7,078,560 $ 6,533,306 $ 3,000,058 $ 6,041,621 $ 22,653,545 At December 31, 2016: $ 6,033,019 $ 5,995,253 $ 3,186,354 $ 6,931,468 $ 22,146,094 Assets acquired Three months ended March 31, 2017 $ 150,329 $ 6,944 $ 11,756 $ 4,500 $ 173,529 Three months ended March 31, 2016 $ 49,893 $ 2,116 $ 24,240 $ 49,824 $ 126,073

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12 – SUBSEQUENT EVENTS Effective May 5, 2017, we appointed Marcum LLP (“Marcum”) as our independent registered public accounting firm. Our engagement was approved by our Board of Directors. We previously reported in our Current Report on Form 8-K (date of Report: May 5, 2017), as filed with the Securities and Exchange Commission on May 9, 2017, our termination of our prior independent registered public accounting firm, RBSM, LLP.

SIGNIFICANT ACCOUNTING POLICI19

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Use of estimates	Use of estimates The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates include the recoverability and useful lives of long-lived assets, provision against bad debt, the fair value of the Company’s stock, and stock-based compensation. Actual results may differ from these estimates.
Revenue recognition	Revenue recognition The Company recognizes revenue when: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed or determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. ASC 605-10 incorporates Accounting Standards Codification subtopic 605-25, “ Multiple-Element Arrangements The Company recognizes in accordance with Accounting Standards Codification subtopic 954-310, “Health Care Entities” (“ASC 954-310”), significant patient service revenue at the time the services are rendered, even though it does not assess the patient’s ability to pay. Therefore, The Company’s interim and annual periods reports disclose both, its policy for assessing and disclosing the timing and amount of uncollectable patient service revenue recognized as doubtful. Qualitative and quantitative information about significant changes in the allowance for doubtful accounts related to patient accounts receivable are disclosed in the Company’s reports. These estimates are based upon the history and identified trends for each of our payers.
Concentrations of credit risk	Concentrations of credit risk The Company’s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. Occasionally, the Company’s cash and cash equivalents in interest-bearing accounts may exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management. Revenues and accounts receivable are concentrated between two major payers, Medicare at approximately 30% and a third party commercial insurer at approximately 20%.
Accounts receivable	Accounts receivables As of March 31, 2017 and December 31, 2016, the Company’s allowance for bad debts was $3,750,802 and $3,680,837, respectively.
Net income per share	Net income per share Basic net income per common share is based upon the weighted-average number of common shares outstanding. Diluted net income per common share is based on the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding and computed as follows: Three months ended March 31, 2017 2016 Numerator: Net income $ 202,519 $ 9,566,941 Denominator: Weighted-average common shares, basic 26,252,505 22,886,307 Weighted-average common shares, diluted 27,052,505 25,552,974 Basic: $ 0.01 $ 0.42 Diluted: $ 0.01 $ 0.37 The diluted earnings per common share included the effect of 800,000 and 2,666,667 common shares issuable upon the conversion of debt for the three months ended March 31, 2017 and 2016, respectively. Potentially dilutive common shares from employee equity plans and issued warrants are determined by applying the treasury stock method to the assumed exercise of warrants and share options are were excluded from the computation of the diluted net income per share because their inclusion would be anti-dilutive. In addition, there were no vested restrict stock for periods presented. Potentially dilutive securities excluded from the basic and diluted net income per share are as follows: March 31, 2017 2016 Warrants to purchase common stock 1,875,000 4,324,630 Options to purchase common stock 3,000,000 3,000,000 Restricted stock awards 660,000 — 5,535,000 7,324,630
Reclassification	Reclassification Certain reclassifications have been made to prior periods’ data to conform to the current year’s presentation. These reclassifications had no effect on reported income or losses.
Recent accounting pronouncements	Recent accounting pronouncements There are updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s financial position, results of operations or cash flows. In January 2017, the FASB issued Accounting Standards Update (“ASU”) 2017-04, Intangibles – Goodwill and Other (Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements.
Subsequent events	Subsequent events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed.

SIGNIFICANT ACCOUNTING POLICI20

SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2017
Significant Accounting Policies Tables
Net Income per share	Potentially dilutive common shares outstanding and computed as follows: Three months ended March 31, 2017 2016 Numerator: Net income $ 202,519 $ 9,566,941 Denominator: Weighted-average common shares, basic 26,252,505 22,886,307 Weighted-average common shares, diluted 27,052,505 25,552,974 Basic: $ 0.01 $ 0.42 Diluted: $ 0.01 $ 0.37 March 31, 2017 2016 Warrants to purchase common stock 1,875,000 4,324,630 Options to purchase common stock 3,000,000 3,000,000 Restricted stock awards 660,000 — 5,535,000 7,324,630

OTHER ASSETS (Tables)

OTHER ASSETS (Tables)	3 Months Ended
	Mar. 31, 2017
Other Assets Tables
Schedule Of Other Assets	Other assets are comprised of the following: March 31, 2017 December 31, 2016 Goodwill (amount relating to VIE of $899,465) $ 899,465 $ 899,465 Deferred costs, net of amortization of $618,401 and $537,740 2,608,026 2,688,687 Patient list, net of accumulated amortization of $100,000 and $95,000 200,000 205,000 Patents, net of accumulated amortization of $62,075 and $57,300 224,425 229,200 Investments (amounts related to VIE of $22,005) 22,005 22,005 Deferred tax asset 181,029 181,029 Deposits 2,571 2,571 Total other assets $ 4,137,521 $ 4,227,957

STOCK OPTIONS, WARRANTS AND R22

STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK UNITS (Tables)	3 Months Ended
	Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes the restricted stock activity for the three months ended March 31, 2017: Restricted shares units issued as of December 31, 2016 660,000 Granted — Forfeited — Total Restricted Shares Issued at March 31, 2017 660,000 Vested at March 31, 2017 — Unvested restricted shares as of March 31, 2017 660,000

VARIABLE INTEREST ENTITY (Table

VARIABLE INTEREST ENTITY (Tables)	3 Months Ended
	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Variable Interest Entities	The tables below summarize the assets and liabilities associated with The B.A.C.K. Center as of March 31, 2017 and December 31, 2016: March 31, 2017 December 31, 2016 Current assets: Cash $ 813,427 $ 355,491 Accounts receivable 4,826,389 4,830,054 Other current assets 772,001 691,847 Total current assets 6,411,817 5,877,392 Property and equipment, net 71,226 70,444 Other assets 22,005 22,005 Total assets $ 6,505,048 $ 5,969,841 Current liabilities: Accounts payable and accrued liabilities $ 1,242,054 $ 904,684 Due to First Choice Healthcare Solutions, Inc. 3,040,529 2,867,539 Other current liabilities 677,447 677,446 Total current liabilities 4,960,030 4,449,669 Long term debt 1,683,704 1,658,858 Total liabilities 6,643,734 6,108,527 Non-controlling interest (138,686 ) (138,686 ) Total liabilities and deficit $ 6,505,048 $ 5,969,841 The tables below summarize the assets and liabilities associated with the Crane Creek as of March 31, 2017 and December 31, 2016: March 31, 2017 December 31, 2016 Current assets: Cash $ 94,714 $ 353,367 Accounts receivable 1,286,577 1,180,907 Other current assets 112,510 129,430 Total current assets 1,493,801 1,663,704 Property and equipment, net 606,792 623,185 Goodwill 899,465 899,465 Total assets $ 3,000,058 $ 3,186,354 March 31, 2017 December 31, 2016 Current liabilities: Accounts payable and accrued liabilities $ 396,094 $ 461,489 Other current liabilities 251,588 251,588 Total current liabilities 647,682 713,077 Deferred rent 556,848 556,051 Total liabilities 1,204,530 1,269,128 Equity-First Choice Healthcare Solutions, Inc. 718,211 766,891 Non-controlling interest 1,077,317 1,150,335 Total liabilities and deficit $ 3,000,058 $ 3,186,354

NON-CONTROLLING INTEREST (Table

NON-CONTROLLING INTEREST (Tables)	3 Months Ended
	Mar. 31, 2017
Non-controlling Interest Tables
Schedule of Net loss attributable to non-controlling interest	Net income attributable to non-controlling interest for the three months ended March 31, 2017: Net income $ 170,842 Average Non-controlling interest percentage of profit/losses -0- % Net income attributable to the non-controlling interest $ -0- Net loss attributable to non-controlling interest for the three months ended March 31, 2016: Net income $ 328,741 Average Non-controlling interest percentage of profit/losses -0- % Net income attributable to the non-controlling interest $ -0- The following table summarizes the changes in non-controlling interest from December 31, 2016 through March 31, 2017: Balance, December 31, 2016 $ (138,686 ) Transfer (to) from the non-controlling interest as a result of change in ownership — Net income attributable to the non-controlling interest — Balance, March 31, 2017 $ (138,686 ) butable to non-controlling interest for the three months ended March 31, 2017: Net loss $ (121,698 ) Average Non-controlling interest percentage of profit/losses 60 % Net income/loss attributable to the non-controlling interest $ (73,018 ) Net income attributable to non-controlling interest for the three months ended March 31, 2016: Net income $ 89,177 Average non-controlling interest percentage of profit/losses 60 % Net income/loss attributable to the non-controlling interest $ 53,507 The following table summarizes the changes in non-controlling interest from December 31, 2016 through March 31, 2017: Balance, December 31, 2016 1,150,335 Transfer (to) from the non-controlling interest as a result of change in ownership — Net income attributable to the non-controlling interest (73,018 ) Balance, March 31, 2017 $ 1,077,317

SEGMENT REPORTING (Tables)

SEGMENT REPORTING (Tables)	3 Months Ended
	Mar. 31, 2017
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	Summary Statement of Income for the three months ended March 31, 2017: The FCID B.A.C.K. Intercompany Medical Center CCSC Corporate Eliminations Total Revenue: Net Patient Service Revenue $ 2,860,986 $ 3,090,579 $ 1,190,425 $ — $ — $ 7,141,990 Rental revenue — 340,076 431,850 (193,563 ) 578,363 Total Revenue 2,860,986 3,430,655 1,190,425 431,850 (193,563 ) 7,720,353 Operating expenses: Salaries & benefits 1,095,236 1,718,717 298,299 242,124 3,354,376 Other operating expenses 591,151 856,482 852,122 408,861 (179,433 ) 2,529,183 General and administrative 525,309 638,798 136,354 249,502 (14,130 ) 1,535,833 Depreciation and amortization 69,741 6,162 28,149 85,436 — 189,488 Total operating expenses 2,281,437 3,220,159 1,314,924 985,923 (193,563 ) 7,608,880 Net income (loss) from operations: 579,549 210,496 (124,499 ) (554,073 ) — 111,473 Interest income (expense) (27,558 ) (3,904 ) (866 ) 254 — (32,074 ) Other income — 45,684 3,668 750 — 50,102 Net Income (Loss) before income taxes: 551,991 252,276 (121,697 ) (553,069 ) — 129,501 Income taxes — — — — Net income (Loss) 551,991 252,276 (121,697 ) (553,069 ) — 129,501 Non-controlling interest — — 73,018 — — 73,018 Net income (loss) attributable to First Choice Healthcare Solutions $ 551,991 $ 252,276 $ (48,679 ) $ (553,069 ) $ — $ 202,519 Summary Statement of Income for the three months ended March 31, 2016: The FCID B.A.C.K. Intercompany Medical Center CCSC Corporate Eliminations Total Revenue: Net Patient Service Revenue $ 2,308,935 $ 3,034,898 $ 1,271,308 $ — $ — $ 6,615,141 Rental revenue — 358,099 428,246 (159,733 ) 626,612 Total Revenue 2,308,935 3,392,997 1,271,308 428,246 (159,733 ) 7,241,753 Operating expenses: Salaries & benefits 829,220 1,457,911 293,337 200,101 — 2,780,569 Other operating expenses 531,407 858,301 709,646 105,954 (159,733 ) 2,045,575 General and administrative 361,803 723,492 109,275 353,006 — 1,547,576 Depreciation and amortization 66,792 5,515 71,256 155,387 — 298,950 Total operating expenses 1,789,222 3,045,219 1,183,514 814,448 (159,733 ) 6,672,670 Net income (loss) from operations: 519,713 347,778 87,794 (386,202 ) — 569,083 Interest income (expense) (56,818 ) (2,459 ) (8,726 ) (113,132 ) — (181,135 ) Amortization of financing costs — (988 ) — (14,337 ) — (15,325 ) Gain on sale of property — — — 9,188,968 — 9,188,968 Other income (expense) — 56,725 1,382 750 — 58,857 Net Income (loss) before income taxes: 462,895 401,056 80,450 8,676,047 — 9,620,448 Income taxes — — — — Net income 462,895 401,056 80,450 8,676,047 — 9,620,448 Non-controlling interest — — (53,507 ) — — (53,507 ) Net income attributable to First Choice Healthcare Solutions $ 462,895 $ 401,056 $ 26,943 $ 8,676,047 $ — $ 9,566,941 Selected financial data: FCID Brevard The Crane Medical Orthopaedic Center Corporate Total Assets: At March 31, 2017: $ 7,078,560 $ 6,533,306 $ 3,000,058 $ 6,041,621 $ 22,653,545 At December 31, 2016: $ 6,033,019 $ 5,995,253 $ 3,186,354 $ 6,931,468 $ 22,146,094 Assets acquired Three months ended March 31, 2017 $ 150,329 $ 6,944 $ 11,756 $ 4,500 $ 173,529 Three months ended March 31, 2016 $ 49,893 $ 2,116 $ 24,240 $ 49,824 $ 126,073

BASIS OF PRESENTATION (Details

BASIS OF PRESENTATION (Details Textual) - $ / shares	3 Months Ended	4 Months Ended	9 Months Ended
	Mar. 31, 2017	May 01, 2015	Oct. 01, 2015
Matures date	Apr. 1, 2016
Options issued to purchase the Company's common stock		3,000,000
Stock Purchase Price		$ 1.35
Crane Creek Surgery Center [Member]
Bearing interest rate			40.00%
Matures date			Apr. 15, 2016
Voting Rights, Description			In connection with the investment, the Company is entitled to 51% voting rights for all decisions that most significantly affect the economic performance of Crane Creek. The 40% equity interest acquired entitles the Company to 40% of the profit or loss of Crane Creek
B.A.C.K. Center [Member]
Options issued to purchase the Company's common stock	3,000,000
Stock Purchase Price	$ 1.35

SIGNIFICANT ACCOUNTING POLICI27

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Numerator:
Net income	$ 202,519	$ 9,566,941
Denominator:
Weighted-average common shares, basic	26,252,505	22,886,307
Weighted-average common shares, diluted	27,052,505	25,552,974
Basic:	$ 0.01	$ 0.42
Diluted:	$ 0.01	$ 0.37

SIGNIFICANT ACCOUNTING POLICI28

SIGNIFICANT ACCOUNTING POLICIES (Details 1) - shares	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	5,535,000	7,324,630
Warrants to purchase common stock [Member]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	1,875,000	4,324,630
Options to purchase common stock [Member]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	3,000,000	3,000,000
Restricted stock awards [Member]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	660,000

SIGNIFICANT ACCOUNTING POLICI29

SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Accounting Policies [Abstract]
Allowance for Doubtful Accounts Receivable	$ 3,750,802	$ 3,680,837
Conversion of debt	$ 2,666,667	$ 800,000

OTHER ASSETS (Details)

OTHER ASSETS (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Other Assets Details
Goodwill (amount relating to VIE of $899,465)	$ 899,465	$ 899,465
Deferred costs, net of amortization of $618,401 and $537,740	2,608,026	2,688,687
Patient list, net of accumulated amortization of $100,000 and $95,000	200,000	205,000
Patents, net of accumulated amortization of $62,075 and $57,300	224,425	229,200
Investments (amounts related to VIE of $22,005)	22,005	22,005
Deferred tax asset	181,029	181,029
Deposits	2,571	2,571
Total other assets	$ 4,137,521	$ 4,227,957

LINES OF CREDIT (Details Textua

LINES OF CREDIT (Details Textual) - USD ($)	Dec. 14, 2015	Jun. 13, 2013	Apr. 09, 2013	Jun. 27, 2012	Mar. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Line of Credit Facility [Line Items]
Line Of Credit Facility, Amount Outstanding		$ 2,000,000			$ 1,100,000	$ 600,000
Debt Instrument, Term	60 days
Line of Credit Facility, Average Outstanding Amount					$ 439,524
Matures date					Apr. 1, 2016
Shares issued convertible debt, Amount					$ 2,236,907
CT Capital LTD [Member]
Line of Credit Facility [Line Items]
Short-term Debt, Maximum Amount Outstanding During Period		$ 2,500,000
Line of Credit Facility, Collateral		The advance rate is defined as: 80% of all receivables to be 120 days or less at the net collection rate of approximately 27% of total billings, excluding patient billings and collections. Additionally, allowable accounts receivable will also include 50% of all accounts receivable protected by legal letters of protection.
Debt Instrument, Convertible, Terms of Conversion Feature		At any time up until December 31, 2016, the Lender may convert all or any portion of the outstanding principal amount or interest on the Loan into common stock of the Company at a conversion price of $0.75 per share.
Debt Instrument, Interest Rate During Period		6.00%
Line Of Credit Facility, Amount Outstanding					$ 1,100,000
Matures date		Jun. 30, 2017			Jun. 30, 2018
TBC Equipment Leasing, LLC member [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Increase (Decrease), Other, Net			$ 995,000
Debt Instrument, Term			45 days
Line of Credit Facility, Average Outstanding Amount			$ 1,000,000
Line of Credit, Florida Business Bank [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Covenant Terms				The advance rate is defined as: 60% of eligible accounts receivables. Eligible receivables include all Medicare and Medicaid receivables less than 90 days old multiplied by a factor of 0.25, plus all other receivables less than 90 days old multiplied by a factor of 0.50. As of March 31, 2017, The B.A.C.K. Center had not violated the loan covenants.
Line Of Credit Guaranteed Amount					$ 950,000
Line of Credit Facility, Average Outstanding Amount						$ 439,524	$ 416,888
Line of Credit, Florida Business Bank [Member] | Accounts Receivable [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Interest Rate During Period				1.00%
Line of Credit Facility, Maximum Borrowing Capacity				$ 1,383,000
Line of Credit Facility, Interest Rate Description				interest rate of Prime floating plus 1.0%, as published in The Wall Street Journal, with a floor of 4.50% per annum (the Loan).
Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases				$ 1,383,000

CAPITAL STOCK (Details Textual)

CAPITAL STOCK (Details Textual)	3 Months Ended
	Mar. 31, 2017USD ($)shares
Stock Issued During Period, Shares, Conversion of Convertible Securities | shares	1,866,667
Stock Issued During Period, Value, Conversion of Convertible Securities | $	$ 1,400,000
Employee Stock Option [Member]
Common Stock, Shares, Issued for Services | shares	306,000
Common Stock, Shares, Issued for Services Amount | $	$ 301,840

STOCK OPTIONS, WARRANTS AND R33

STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK UNITS (Details) - Restricted Stock [Member]	3 Months Ended
	Mar. 31, 2017shares
Restricted shares units issued as of December 31, 2016	660,000
Number of Shares, Granted
Number of Shares, Forfeited
Number of Shares, Outstanding	660,000
Vested at March 31, 2017
Unvested restricted shares as of March 31, 2017	660,000

STOCK OPTIONS, WARRANTS AND R34

STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK UNITS (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Fair value restricted stock vesting	$ 63,324	$ 0
Stock based compensation related to restricted stock	$ 488,830		$ 552,154
Weighted average remaining period	2 years 1 month 17 days
Probability the performance	100.00%

VARIABLE INTEREST ENTITY (Detai

VARIABLE INTEREST ENTITY (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash	$ 3,901,489	$ 4,593,638	$ 10,051,999	$ 1,594,998
Accounts receivable	10,390,140	9,536,830
Total current assets	15,896,531	15,373,321
Property and equipment, net	2,619,493	2,544,816
Other assets	4,137,521	4,227,957
Total assets	22,653,545	22,146,094
Current liabilities:
Accounts payable and accrued liabilities	2,437,080	2,083,231
Total current liabilities	5,093,370	4,839,683
Total liabilities	7,504,364	7,189,738
Non-controlling interest	938,631	1,011,649
Total liabilities and deficit	22,653,545	22,146,094
B.A.C.K. Center [Member]
Current assets:
Cash	813,427	355,491
Accounts receivable	4,826,389	4,830,054
Other current assets	772,001	691,847
Total current assets	6,411,817	5,877,392
Property and equipment, net	71,226	70,444
Other assets	22,005	22,005
Total assets	6,505,048	5,969,841
Current liabilities:
Accounts payable and accrued liabilities	1,242,054	904,684
Due to First Choice Healthcare Solutions, Inc.	3,040,529	2,867,539
Other current liabilities	677,447	677,446
Total current liabilities	4,960,030	4,449,669
Long term debt	1,683,704	1,658,858
Total liabilities	6,643,734	6,108,527
Non-controlling interest	(138,686)	(138,686)
Total liabilities and deficit	$ 6,505,048	$ 5,969,841

VARIABLE INTEREST ENTITY (Det36

VARIABLE INTEREST ENTITY (Details 1) - USD ($)	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash	$ 3,901,489	$ 4,593,638	$ 10,051,999	$ 1,594,998
Accounts receivable	10,390,140	9,536,830
Total current assets	15,896,531	15,373,321
Property and equipment, net	2,619,493	2,544,816
Goodwill	899,465	899,465
Total assets	22,653,545	22,146,094
Current liabilities:
Accounts payable and accrued liabilities	2,437,080	2,083,231
Total current liabilities	5,093,370	4,839,683
Deferred rent	2,345,465	2,293,594
Total liabilities	7,504,364	7,189,738
Equity-First Choice Healthcare Solutions, Inc	26,804	24,631
Non-controlling interest	938,631	1,011,649
Total liabilities and deficit	22,653,545	22,146,094
Crane Creek Surgery Center [Member]
Current assets:
Cash	94,714	353,367
Accounts receivable	1,286,577	1,180,907
Other current assets	112,510	129,430
Total current assets	1,493,801	1,663,704
Property and equipment, net	606,792	623,185
Goodwill	899,465	899,465
Total assets	3,000,058	3,186,354
Current liabilities:
Accounts payable and accrued liabilities	396,094	461,489
Other current liabilities	251,588	251,588
Total current liabilities	647,682	713,077
Deferred rent	556,848	556,051
Total liabilities	1,204,530	1,269,128
Equity-First Choice Healthcare Solutions, Inc	718,211	766,891
Non-controlling interest	1,077,317	1,150,335
Total liabilities and deficit	$ 3,000,058	$ 3,186,354

VARIABLE INTEREST ENTITY (Det37

VARIABLE INTEREST ENTITY (Details Textual) - USD ($)	3 Months Ended		4 Months Ended	9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	May 01, 2015	Oct. 01, 2015
Options issued to purchase the Company's common stock			3,000,000
Total revenues	$ 7,720,353	$ 7,241,753	$ 9,789,366
Salaries and benefits	3,354,376	2,780,569	4,084,312
Operating expenses	7,608,880	6,672,670
General and administrative expenses	1,535,833	1,547,576	3,928,244
Depreciation			18,404
Interest and financing costs	(32,074)	(181,135)	$ 28,524
Other income (expense)	$ 50,102	58,857
Matures date	Apr. 1, 2016
Stock Purchase Price			$ 1.35
Crane Creek Surgery Center [Member]
Total revenues	$ 1,190,425	1,271,308
Salaries and benefits	298,299	293,337
Operating expenses	852,122	709,646
General and administrative expenses	136,354	109,275
Depreciation	28,149	71,256
Interest and financing costs	866	8,726
Miscellaneous income	3,668	1,382
Bearing interest rate				40.00%
Matures date				Apr. 15, 2016
Voting Rights, Description				In connection with the investment, the Company is entitled to 51% voting rights for all decisions that most significantly affect the economic performance of Crane Creek. The 40% equity interest acquired entitles the Company to 40% of the profit or loss of Crane Creek
Gain on sale of equipment	$ 18,878
Crane Creek Surgery Center One [Member]
Matures date				Apr. 15, 2016
Voting Rights, Description				In connection with the investment, the Company is entitled to 51% voting rights for all decisions that most significantly affect the economic performance of Crane Creek. The 40% equity interest acquired entitles the Company to 40% of the profit or loss of Crane Creek
B.A.C.K. Center [Member]
Options issued to purchase the Company's common stock	3,000,000
Total revenues	$ 3,430,655	3,392,997
Salaries and benefits	1,718,717	1,457,911
Operating expenses	856,482	858,301
General and administrative expenses	720,232	723,492
Depreciation	6,162	5,515
Interest and financing costs	3,904	3,447
Other income (expense)	$ 45,684	$ 56,725
Stock Purchase Price	$ 1.35

NON-CONTROLLING INTEREST (Detai

NON-CONTROLLING INTEREST (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Net income loss attributable to the non-controlling interest	$ 73,018	$ (53,507)
B.A.C.K. Center [Member]
Net income	$ 170,842	$ 328,741
Average Non-controlling interest percentage of profit/losses	0.00%	(0.00%)
Net income loss attributable to the non-controlling interest	$ 0	$ 0
CCSC HoldingsInc [Member]
Net income	$ (121,698)	$ 89,177
Average Non-controlling interest percentage of profit/losses	60.00%	60.00%
Net income loss attributable to the non-controlling interest	$ (73,018)	$ 53,507

NON-CONTROLLING INTEREST (Det39

NON-CONTROLLING INTEREST (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Balance, December 31, 2016	$ 1,011,649
Net income loss attributable to the non-controlling interest	73,018	$ (53,507)
Balance, March 31, 2017	938,631
B.A.C.K. Center [Member]
Balance, December 31, 2016	(138,686)
Net income loss attributable to the non-controlling interest	0	0
Balance, March 31, 2017	(138,686)
CCSC HoldingsInc [Member]
Balance, December 31, 2016	1,150,335
Transfer (to) from the non-controlling interest as a result of change in ownership
Net income loss attributable to the non-controlling interest	(73,018)	$ 53,507
Balance, March 31, 2017	$ 1,077,317

NON-CONTROLLING INTEREST (Det40

NON-CONTROLLING INTEREST (Details Textual) - $ / shares	3 Months Ended	4 Months Ended	9 Months Ended
	Mar. 31, 2017	May 01, 2015	Oct. 01, 2015
Matures date	Apr. 1, 2016
Options issued to purchase the Company's common stock		3,000,000
Stock Purchase Price		$ 1.35
Crane Creek Surgery Center [Member]
Matures date			Apr. 15, 2016
Voting Rights, Description			In connection with the investment, the Company is entitled to 51% voting rights for all decisions that most significantly affect the economic performance of Crane Creek. The 40% equity interest acquired entitles the Company to 40% of the profit or loss of Crane Creek
B.A.C.K. Center [Member]
Options issued to purchase the Company's common stock	3,000,000
Stock Purchase Price	$ 1.35

SEGMENT REPORTING (Details)

SEGMENT REPORTING (Details) - USD ($)	3 Months Ended		4 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	May 01, 2015	Dec. 31, 2016
Revenue:
Net patient service revenue	$ 7,141,990	$ 6,615,141
Rental revenue	578,363	626,612
Total revenue	7,720,353	7,241,753	$ 9,789,366
Operating expenses:
Salaries & benefits	3,354,376	2,780,569	4,084,312
Other operating expenses	2,529,183	2,045,575
General and administrative	1,535,833	1,547,576	3,928,244
Depreciation and amortization	189,488	298,950
Total operating expenses	7,608,880	6,672,670
Net income (loss) from operations:	111,473	569,083
Interest income (expense)	(32,074)	(181,135)	$ 28,524
Amortization of financing costs		15,325
Gain on sale of property		9,188,968
Other income	50,102	58,857
Net Income (loss) before income taxes:	129,501	9,620,448
Income taxes
Net income (loss)	129,501	9,620,448
Non-controlling interest	73,018	(53,507)
Net income (loss) attributable to First Choice Healthcare Solutions	202,519	9,566,941
Assets:	22,653,545			$ 22,146,094
Assets acquired	173,529	126,073
FCID Medical [Member]
Revenue:
Net patient service revenue	2,860,986	2,308,935
Rental revenue
Total revenue	2,860,986	2,308,935
Operating expenses:
Salaries & benefits	1,095,236	829,220
Other operating expenses	591,151	531,407
General and administrative	525,309	361,803
Depreciation and amortization	69,741	66,792
Total operating expenses	2,281,437	1,789,222
Net income (loss) from operations:	579,549	519,713
Interest income (expense)	(27,558)	(56,818)
Amortization of financing costs
Gain on sale of property
Other income
Net Income (loss) before income taxes:	551,991	462,895
Income taxes
Net income (loss)	551,991	462,895
Non-controlling interest
Net income (loss) attributable to First Choice Healthcare Solutions	551,991	462,895
Assets:	7,078,560			6,033,019
Assets acquired	150,329	49,893
Brevard Orthopaedic [Member]
Revenue:
Net patient service revenue	3,090,579	3,034,898
Rental revenue	340,076	358,099
Total revenue	3,430,655	3,392,997
Operating expenses:
Salaries & benefits	1,718,717	1,457,911
Other operating expenses	856,482	858,301
General and administrative	638,798	723,492
Depreciation and amortization	6,162	5,515
Total operating expenses	3,220,159	3,045,219
Net income (loss) from operations:	210,496	347,778
Interest income (expense)	(3,904)	(2,459)
Amortization of financing costs		(988)
Gain on sale of property
Other income	45,684	56,725
Net Income (loss) before income taxes:	252,276	401,056
Net income (loss)	252,276	401,056
Non-controlling interest
Net income (loss) attributable to First Choice Healthcare Solutions	252,276	401,056
Assets:	6,533,306			5,995,253
Assets acquired	6,944	2,116
The Crane Center [Member]
Revenue:
Net patient service revenue	1,190,425	1,271,308
Total revenue	1,190,425	1,271,308
Operating expenses:
Salaries & benefits	298,299	293,337
Other operating expenses	852,122	709,646
General and administrative	136,354	109,275
Depreciation and amortization	28,149	71,256
Total operating expenses	1,314,924	1,183,514
Net income (loss) from operations:	(124,499)	87,794
Interest income (expense)	(866)	(8,726)
Amortization of financing costs
Gain on sale of property
Other income	3,668	1,382
Net Income (loss) before income taxes:	(121,697)	80,450
Net income (loss)	(121,697)	80,450
Non-controlling interest	73,018	(53,507)
Net income (loss) attributable to First Choice Healthcare Solutions	(48,679)	26,943
Assets:	3,000,058			3,186,354
Assets acquired	11,756	24,240
Corporate [Member]
Revenue:
Net patient service revenue
Rental revenue	431,850	428,246
Total revenue	431,850	428,246
Operating expenses:
Salaries & benefits	242,124	200,101
Other operating expenses	408,861	105,954
General and administrative	249,502	353,006
Depreciation and amortization	85,436	155,387
Total operating expenses	985,923	814,448
Net income (loss) from operations:	(554,073)	(386,202)
Interest income (expense)	254	(113,132)
Amortization of financing costs		(14,337)
Gain on sale of property		9,188,968
Other income	750	750
Net Income (loss) before income taxes:	(553,069)	8,676,047
Income taxes
Net income (loss)	(553,069)	8,676,047
Non-controlling interest
Net income (loss) attributable to First Choice Healthcare Solutions	(553,069)	8,676,047
Assets:	6,041,621			$ 6,931,468
Assets acquired	4,500	49,824
Intercompanyt Elimination [Member]
Revenue:
Net patient service revenue
Rental revenue	(193,563)	(159,733)
Total revenue	(193,563)	(159,733)
Operating expenses:
Salaries & benefits
Other operating expenses	(179,433)	(159,733)
General and administrative	(14,130)
Depreciation and amortization
Total operating expenses	(193,563)	(159,733)
Net income (loss) from operations:
Interest income (expense)
Amortization of financing costs
Gain on sale of property
Other income
Net Income (loss) before income taxes:
Income taxes
Net income (loss)
Non-controlling interest
Net income (loss) attributable to First Choice Healthcare Solutions